World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12614000808640
Date of registration: 30/07/2014
Prospective Registration: No
Primary sponsor: Benha university hospital
Public title: Can treatment of unexplained recurrent abortion patients with nitric oxide donors decrease the incidence of abortion?
Scientific title: Comparative study between folic acid control group and folic acid plus isosorbid mononitrate as a nitric oxide donors study group treatment of unexplained recurrent abortion patients as regards incidence of abortion
Date of first enrolment: 01/01/2013
Target sample size: 60
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12614000808640.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial;  
Phase: 
Countries of recruitment
Egypt
Contacts
Name: Prof Mohamed Abdelrazik   
Address:  Department of Obstetrics and Gynecology, Benha Faculty of Medicine, Benha, Farid Nada street Egypt
Telephone: +20 02 26070837 or +20 013 3225385
Email: Prof.mohamedabdelrazik@hotmail.com
Affiliation: 
Name: Prof Mohamed Abdelrazik   
Address:  Department of Obstetrics and Gynecology, Benha Faculty of Medicine, Benha, Farid Nada street Egypt
Telephone: +20 02 26070837 or +20 013 3225385
Email: Prof.mohamedabdelrazik@hotmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Patients with unexplained recurrent abortion with normal uterine cavity, normal glucose tolerance, normal levels of antiphospholipid antibodies, normal thyroid functions and normal karyotyping
Exclusion criteria: Patients treated with vasodilators

Age minimum: 20 Years
Age maximum: 30 Years
Gender: Females
Health Condition(s) or Problem(s) studied
Reproductive Health and Childbirth - Fertility including in vitro fertilisation
Unexplained recurrent abortion;
Unexplained recurrent abortion
Intervention(s)
A control of 30 patients with unexplained recurrent abortion treated with folic acid 0.5 mg once daily orally starting before pregnancy until 20 weeks gestation and a study group of 30 patients treated with folic acid 0.5 mg once daily orally plus isosorbid mononitrate 20 mg dailly applied vaginally
Primary Outcome(s)
Uterine artery resistance and pulsation indices before treatment and at 20 weeks gestation after treatment measured by trans-vaginal and trans-abdominal pulsed color Doppler ultrasound [20 weeks gestation]
Incidence of abortion in both groups[20 weeks gestation]
Secondary Outcome(s)
Nil[Nil]
Secondary ID(s)
Nil
Source(s) of Monetary Support
Benha university hospital
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history